SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jahaira Lopez-Pastrana, Ying Shao, Valeria Chernaya, Hong Wang, Xiao-Feng Yang, Epigenetic enzymes are the therapeutic targets for CD4+CD25+/highFoxp3+ regulatory T cells, Translational Research, 2015, 165, 1, 221

    CrossRef

  2. 2
    Ryan A. Wilcox, Cutaneous T-cell lymphoma: 2014 Update on diagnosis, risk-stratification, and management, American Journal of Hematology, 2014, 89, 8
  3. 3
    Bláithín Moriarty, Sean Whittaker, Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma, Expert Review of Hematology, 2014, 1

    CrossRef

  4. 4
    D. J. Straus, M. Duvic, S. M. Horwitz, K. Hymes, A. Goy, F. J. Hernandez-Ilizaliturri, T. Feldman, B. Wegner, P. L. Myskowski, Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma, Annals of Oncology, 2014, 25, 1, 206

    CrossRef

  5. 5
    Maxim Polansky, Rakhshandra Talpur, Seema Daulat, Chitra Hosing, Bouthaina Dabaja, Madeleine Duvic, Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome, Clinical Lymphoma Myeloma and Leukemia, 2014,

    CrossRef

  6. 6
    Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, Alison Moskowitz, Christiane Querfeld, Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome), Journal of the American Academy of Dermatology, 2014, 70, 2, 223.e1

    CrossRef

  7. 7
    Gregory M. Cote, Edwin Choy, Role of Epigenetic Modulation for the Treatment of Sarcoma, Current Treatment Options in Oncology, 2013, 14, 3, 454

    CrossRef

  8. 8
    J.J. Scarisbrick, S. Morris, R. Azurdia, T. Illidge, E. Parry, R. Graham-Brown, R. Cowan, E. Gallop-Evans, R. Wachsmuth, M. Eagle, A.S. Wierzbicki, H. Soran, S. Whittaker, E.M. Wain, U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma, British Journal of Dermatology, 2013, 168, 1
  9. 9
    Uwe Wollina, Cutaneous T cell lymphoma: update on treatment, International Journal of Dermatology, 2012, 51, 9
  10. 10
    Andrea Gulia, Cesare Massone, Primary cutaneous T-cell lymphomas, Journal of the Egyptian Womenʼs Dermatologic Society, 2012, 9, 1, 1

    CrossRef

  11. You have free access to this content11
    Ryan A. Wilcox, Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management, American Journal of Hematology, 2011, 86, 11
  12. 12
    Rakhshandra Talpur, Marie Francis Demierre, Larisa Geskin, Elma Baron, Silvina Pugliese, Kelley Eubank, John A. Zic, Donald R. Miller, Michael Tharp, Kimberly Bohjanen, Madeleine Duvic, Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides, Clinical Lymphoma Myeloma and Leukemia, 2011, 11, 2, 219

    CrossRef

  13. 13
    Elise A. Olsen, Alain H. Rook, John Zic, Youn Kim, Pierluigi Porcu, Christiane Querfeld, Gary Wood, Marie-France Demierre, Mark Pittelkow, Lynn D. Wilson, Lauren Pinter-Brown, Ranjana Advani, Sareeta Parker, Ellen J. Kim, Jacqueline M. Junkins-Hopkins, Francine Foss, Patrick Cacchio, Madeleine Duvic, Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC), Journal of the American Academy of Dermatology, 2011, 64, 2, 352

    CrossRef

  14. 14
    Joseph R. Carver, Supportive Oncology, 2011,

    CrossRef

  15. 15
    Liyan Qu, Xiuwen Tang, Bexarotene: a promising anticancer agent, Cancer Chemotherapy and Pharmacology, 2010, 65, 2, 201

    CrossRef

  16. 16
    Joslyn S Kirby, Ellen J Kim, Alain H Rook, Therapy of Sézary syndrome, Expert Review of Dermatology, 2009, 4, 6, 567

    CrossRef

  17. 17
    Jennifer M Gardner, Katherine G Evans, Amy Musiek, Alain H Rook, Ellen J Kim, Update on treatment of cutaneous T-cell lymphoma, Current Opinion in Oncology, 2009, 21, 2, 131

    CrossRef

  18. You have free access to this content18
    Current Awareness in Hematological Oncology, Hematological Oncology, 2008, 26, 1
  19. 19
    M. Bagot, Linfomas T cutáneos, EMC - Dermatología, 2008, 42, 4, 1

    CrossRef

  20. 20
    M. Bagot, Lymphomes T cutanés, EMC - Dermatologie, 2008, 3, 3, 1

    CrossRef

  21. 21
    Steven M. Horwitz, Novel Therapies for Cutaneous T-Cell Lymphomas, Clinical Lymphoma and Myeloma, 2008, 8, S187

    CrossRef

  22. 22
    Evangelia Papadavid, Christina Antoniou, Vassiliki Nikolaou, Marina Siakantaris, Theodoros P Vassilakopoulos, Alexandros Stratigos, Nikolaos Stavrianeas, Andreas Katsambas, Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides, American Journal of Clinical Dermatology, 2008, 9, 3, 169

    CrossRef

  23. 23
    Joseph R. Carver, Chaitali J. Desai, Cardiovascular Toxicity of Antitumor Drugs: Dimension of the Problem in Adult Settings,
  24. 24
    Mycosis Fungoides,
  25. 25
    Fiona Child, Sean Whittaker, Primary Cutaneous T-cell Lymphoma,
  26. 26
    Marcia I. Dawson, Retinoids, Burger's Medicinal Chemistry and Drug Discovery,